Affiliation: Merck Research Laboratories
- Prevalence and predictors of lipid abnormalities in patients treated with statins in the UK general practiceH Phatak
Merck and Co, Inc, 1 Merck Drive, WS2E 60, Whitehouse Station, NJ 08889, USA
Atherosclerosis 202:225-33. 2009..To identify the prevalence and predictors of lipid abnormalities in statin-treated patients in the UK...
- Lipid testing among patients beginning statin therapy in general practice in the United KingdomHemant Phatak
Merck and Co, Inc, Whitehouse Station, NJ 08889, USA
Value Health 11:933-8. 2008..To determine the frequency of lipid testing and to identify the factors predictive of lipid-testing frequency over a 1-year period in patients beginning statin treatment...
- Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research DatabaseVasilisa Sazonov
Global Outcomes Research and Reimbursement, Merck and Co Inc, One Merck Drive, Whitehouse Station, NJ 08889, USA
Atherosclerosis 208:210-6. 2010....
- Impact of worsening renal function during hospital admission on resource utilization in patients with heart failurePeter M Herout
EPI Q, Inc, Oak Brook, Illinois, USA
Am J Cardiol 106:1139-45. 2010..001) and longer hospital stay (8.2 ± 6.8 vs 5.7 ± 5.5 days, p < 0.001). In conclusion, occurrence of WRF during HF-related hospitalization is associated with higher hospitalization costs and longer hospital stay...